Growth Metrics

Tandem Diabetes Care (TNDM) Capital Expenditures (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -67.21%
Dec 31, 2025 7,967.49%
Sep 30, 2025 87.16%
Jun 30, 2025 -163.81%
Mar 31, 2025 118.94%
Dec 31, 2024 -398.74%
Sep 30, 2024 -18.98%
Jun 30, 2024 45.08%
Mar 31, 2024 123.89%
Dec 31, 2023 -445.54%
Sep 30, 2023 -55.50%
Jun 30, 2023 198.06%
Mar 31, 2023 -27.65%
Dec 31, 2022 -58.96%
Sep 30, 2022 13.15%
Jun 30, 2022 358.46%
Mar 31, 2022 -80.03%
Dec 31, 2021 2,584.58%
Sep 30, 2021 204.45%
Jun 30, 2021 -151.08%
Mar 31, 2021 272.39%
Dec 31, 2020 -183.62%
Sep 30, 2020 111.07%
Jun 30, 2020 -185.56%
Mar 31, 2020 -60.33%
Dec 31, 2019 659.78%
Sep 30, 2019 292.04%
Jun 30, 2019 -183.03%
Mar 31, 2019 -51.93%
Dec 31, 2018 8,468.57%
Sep 30, 2018 72.00%
Jun 30, 2018 -157.60%
Mar 31, 2018 -96.16%
Dec 31, 2017 241.75%
Sep 30, 2017 -204.10%
Jun 30, 2017 1,570.74%
Mar 31, 2017 -91.65%
Dec 31, 2016 28.24%
Sep 30, 2016 -40.70%
Jun 30, 2016 717.91%
Mar 31, 2016 -73.59%
Dec 31, 2015 -35.37%
Sep 30, 2015 183.96%
Jun 30, 2015 51.67%
Mar 31, 2015 -19.57%
Dec 31, 2014 -23.09%
Sep 30, 2014 -9.35%
Jun 30, 2014 -33.95%
Mar 31, 2014 9.46%
Dec 31, 2013 32.86%
Sep 30, 2013 116.32%
Jun 30, 2013 -42.85%